Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Prostate Rapid Reference Set Application: Chan/Beckman Coulter (2007)

Prostate Rapid Reference Set Application: Chan/Beckman Coulter (2007)

284
PSA, free PSA, [-2]proPSA, BPSA and testosterone
Proteomics
Prostate and Urologic Cancers Research Group
1

Evaluate performance of [-2]proPSA as an early detection marker for prostate cancer

Specimens were analyzed in a blinded fashion at Beckman Coulter, Inc. on the Beckman Coulter ACCESS 2 immunoassay system for PSA, free PSA, [-2]proPSA, BPSA and testosterone. The PSA assays are all dual monoclonoal sandwich assays using Hybritech antibodies and chemiluminescent detection system. The assays for PSA, free PSA and testosterone are commercially available which the assays for [-2]proPSA and BPSA are for research use only.

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


News

The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 03/06/2014

Thank you to everyone who helped make the 27th EDRN Steering Committee Meeting a success. We look forward to seeing everyone at the 9th EDRN Scientific Workshop from September 8-11, 2014 in Washington D.C.

Announcement